InMed Pharmaceuticals Inc (NASDAQ:INM)

1.92
Delayed Data
As of Jan 26
 -0.01 / -0.52%
Today’s Change
1.23
Today|||52-Week Range
35.50
-4.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization80.2K65.8K73.7K92.8K
 
 
 
 
 
 
Operating ExpensesGross Income-80.2K-65.8K-73.7K-92.8K
 
 
 
 
 
General Expenses3.6M1.7M3.3M6.7M
 
 
 
 
 
Research And Development804.5K285.7K562.5K1.5M
 
 
 
 
 
Total Operating Expenses3.7M1.8M3.4M6.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.7M-1.8M-3.4M-6.8M
 
 
 
 
 
Other Expenses-1.9K-20.00-240.00230.00
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.7M-1.8M-3.4M-6.7M
 
 
 
 
 
Net Income-3.7M-1.8M-3.4M-6.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS46.1M60.2M96.8M142.5M
 
 
 
 
 
Shares To Calculate EPS Diluted46.1M60.2M96.8M142.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.03-$0.04-$0.05
 
 
 
 
 
EPS Diluted-$0.08-$0.03-$0.04-$0.05